Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Danaher's quarterly results show signs of life, and the struggling stock soars
These are the 4 biggest things we're watching in the stock market in the week ahead
Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival
Eli Lilly shares surge on new obesity pill data. What it means for the stock from here
UnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers
